Kao Corporation

Tetsuro Kamiya

Hidenori Yorozu

Kaoru Tsujii

Yasuteru Eguchi

Kenji Hara

Takeshi Inoue

Mitsuyuki Hotta

Kouichi Niinaka

Seiji Kosemura

Katsunori Aizawa

Seiji Kikuta

Hiromichi Takahashi

Masaki Iwasaki

Michitaka Sawada

Shuichi Tsuchiya

Katsuhiko Takeuchi

Keiko Morioka

A bathing preparation is disclosed, comprising bathing agent components packed in a bag which is made of; a nonwoven or woven fabric consisting of a water soluble polymer fiber or a laminate sheet comprising a nonwoven or woven fabric consisting of a water soluble polymer fiber on the outside and a water soluble film on the inside.

Bathing preparation

A patch is disclosed, which comprises a water-soluble adhesive sheet (a), and a patch is disclosed, which comprises a water-soluble adhesive sheet (a) and a water-soluble protective material (b) laminated thereon. This patch is convenient in handling and achieves high merit. Also, it can be applied to the skin so as to exhibit excellent warm-bathing effects on the application site.

Patch

A vasodilating agent and a hair growth promoting agent comprising an extract of hypericum erectum thunb as an effective component are disclosed. The hypericum erectum thunb extract is prepared from ground leaf, stem, root, fruit, seed, or flower of hypericum erectum thunb by extraction with an organic solvent. It is effective for curing or preventing diseases caused by disorder in blood circulation such as hypertension, angina pectories, myocardial infarction, congestive heart failure, frostbite, chilblain, cold constitution, and alopecia.

Vasodilating agent

A percutaneous absorption accelerator and a percutaneous absorbent preparation containing the same and, more particularly, a percutaneous absorption accelerator containing either derivatives of specific glycerols or polyglycerols and alcohols as effective components and a percutaneous absorbent preparation containing the percutaneous absorption accelerators and pharmaceutically effective components.

Percutaneous absorption accelerator and preparation containing same

Novel external medications comprise, as essential components, the following three components (A) to (C):

External medication for skin

A percutaneous absorption accelerator and a precutaneous absorbent preparation containing the same and, more particularly, a percutaneous absorption accelerator containing ether derivatives of specific glycerols or polyglycerols and alcohols as effective components and a percutaneous absorbent preparation containing the percutaneous absorption accelerators and pharmaceutically effective components.

Precutaneous absorption accelerator and preparation containing same

A medical composition for external application comprises a dialkyl phosphate represented by the formula: ##STR1## wherein R.sub.1 and R.sub.2 independently represent a hydrocarbon group having from 6 to 24 carbon atoms, R.sub.3 and R.sub.4 independently represent hydrocarbon group having from 2 to 6 carbon atoms, m and n independently represent a value of from 0 to 20, and x represents a hydrogen atom or a salt of an alkali metal and the like. In the presence of the dialkyl phosphate, percutaneous intake of medically active ingredients is highly enhanced. Examples of the medically active ingredients directed to in the invention include antiinflammatory agents such as ethyl aminobenzoate; adrenocortical hormones such as hydrocortisone; etc. The inventive composition is highly safe without giving any stimulation to the skin.

Growing community of inventors

Tochigi, Japan

Tetsuro Kamiya